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Abstract
Background In 2006, a single-center Swedish study
demonstrated a low rupture rate and high patient satisfac-
tion with the Style 410 shaped, form-stable gel implant.
The current study aimed to validate the accuracy of the
previously published results across multiple European
sites.
Methods A total of 163 subjects (*70% had augmenta-
tion [n = 112], 15% had reconstruction [n = 25], and 15%
had revision [n = 26]) underwent a physical examination
followed by breast magnetic resonance imaging (MRI) for
rupture detection. These subjects had been implanted for 5
to 11 years with at least one Style 410 shaped gel breast
implant before examination. The secondary end points
included lactation, reproductive and breast disease history
before and after implantation, and quality-of-life mea-
surements and complications after implantation.
Results The implant rupture rate was 1.7% a median of
8 years after implantation. Capsular contracture was the
most common complication noted at the physical exami-
nation, occurring for 5.3% of implants, and there were no
cases of grade 4 capsular contracture. The postimplantation
rates for lactation and reproductive problems and breast
disease were lower than the preimplantation rates. Breast
implantation surgery was considered advantageous by 91%
of the subjects, demonstrating high patient satisfaction.
Conclusions The Style 410 anatomically shaped, form-
stable gel breast implants demonstrated long-term safety
and effectiveness.
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DOI 10.1007/s00266-009-9360-xThe long-term safety and effectiveness of Style 410 shaped
gel breast implants (Allergan, Santa Barbara, CA, USA)
were previously studied by Hede ´n et al. [1] at Akademik-
liniken Hospital in Sweden. This was the ﬁrst trial to use
magnetic resonance imaging (MRI) rupture detection for
Style 410 implants 5 or more years after implantation.
Notably, the ﬁndings showed that the MRI rupture signs for
these highly cohesive gel implants were the same as those
for standard gel implants. Although that single-center study
demonstrated a low rupture rate and high patient satisfac-
tion with the Style 410 implant, the study needed to be
validated further across multiple sites to conﬁrm the
accuracy of the results. The current study is similar in
design to the Hede ´n trial but expands the subject cohort to
include seven sites across Europe.
Subjects and Methods
Study Design
The multicenter study was conducted in six European
countries (Sweden, Switzerland, Belgium, Denmark, Fin-
land, and The Netherlands [2 sites]) to investigate the
safety and effectiveness of Style 410 implants 5 to 11 years
after implantation. A total of 163 subjects (*70% had
augmentation [n = 112], 15% had reconstruction [n = 25],
and 15% had revision [n = 26]) underwent a physical
examination followed by a breast MRI between August
2005 and December 2007.
The seven investigational sites were selected on the
basis of professional training and experience in aesthetic
and reconstructive surgery, prior experience conducting
clinical studies, and history of implanting the devices being
studied. Informed consent was obtained from all the sub-
jects, and ethics committees provided oversight.
The data collected at the physical examination included
certain local complications; the subjects’ histories of
lactation, reproduction, and breast disease; and the inves-
tigator’s assessment of rupture status. The subjects com-
pleted a quality-of-life questionnaire to assess changes in
their lives due to the breast implantation surgery.
All MRIs were performed ‘‘closed’’ with the use of a
bilateral dedicated breast coil with unilateral and bilateral
switch positions. The local MRI facility was blinded to the
Investigator’s clinical judgment of whether the implants
were ruptured. The MRI facility forwarded the MRI images
on ﬁlms or disk to the Investigator, who in turn forwarded
the images to the MRI Central Reviewer in the United
States, a radiologist with extensive experience interpreting
MRIs of Style 410 implants.
The Central Reviewer examined all the images to
determine rupture. One of four possible outcomes was
assigned to each image: 1 (no evidence of rupture), 2
(evidence of rupture), 3 (indeterminate outcome), and 4
(unreadable image). A rupture diagnosis was made when
clear evidence on the images showed the linguini sign,
subcapsular line, or inverted loop. The absence of these
signs resulted in a diagnosis of no rupture. An indetermi-
nate ﬁnding signiﬁed an image suggestive of rupture but
not deﬁnitive.
Subjects
The subjects were required to be women who had under-
gone implantation with an Allergan Style 410 shaped gel
breast implant between the years 1995 and 2001 and
retained at least one original implant. The subjects also had
to be willing and eligible to undergo an MRI scan (e.g., no
implanted metal or metal devices, no current pregnancy or
breastfeeding, and no history of severe claustrophobia).
Based on the indication for implantation, the subjects
were classiﬁed into one of three cohorts as follows: aug-
mentation (subject dissatisfaction with breast size or shape,
asymmetry, ptosis, or aplasia), reconstruction (mastectomy
for cancer or trauma, prophylactic mastectomy, or contra-
lateral asymmetry of the nonreconstructed breast), or
revision (previous augmentation or reconstruction with
silicone- or saline-ﬁlled breast implants).
Devices
The Style 410 implants have an anatomic shape similar to
the natural breast shape compared with the round shape of
standard implants. They are ﬁlled with a highly cohesive gel
to create a form-stable device that provides a long-lasting
result in vivo [1]. Biocell texturing on the implant shell
promotes tissue adherence to reduce implant rotation and
capsular contracture [2]. Style 410 implants are available in
a wide range of shapes (a matrix involving 12 combinations
of implant height and projection ratios that extend across a
range of base widths), enabling the physician to select an
implant appropriate to each patient’s needs.
Statistical Analyses
All eligible subjects and implants were pooled to form one
cohort for analysis. The primary end point was the preva-
lence of rupture according to MRI results. Secondary
analyses of MRI rupture ﬁndings were stratiﬁed by years of
implantation, with implant age rounded to the nearest year.
Implant age (time elapsed in vivo) was calculated as the
time from the date of implantation until the date of a
subject’s MRI procedure.
Descriptive statistics tabulated the frequency of local
complications after implantation, pre- and postimplantation
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123lactation and reproduction problems, and the occurrence of
breast disease. Quality-of-life questions concerning general
and speciﬁc changes in subjects’ lives due to breast
implantation surgery were rated on a 7-point scale and then
categorized with the responses of ‘‘much,’’ ‘‘quite,’’ and ‘‘a
bit’’ grouped together to show the percentage of subjects
improved, unchanged, or worsened after implantation.
Results
Subject and Surgical Characteristics
The demographic data showed that most of the subjects
were white and married (Table 1), with a median age of
43 years (range, 25–83 years). The majority of the 163
subjects received implants for cosmetic augmentation
(n = 112), although reconstruction (n = 25) and revision
(n = 26) subjects also were represented. Most of the
subjects underwent MRI screening on the same day as
the physical exam, with a median time of 0 days (range,
0–63 days) elapsed between exam and MRI.
The majority of the 300 devices were placed in a sub-
glandular position using an inframammary incision site
(Table 2). The most commonly used implant was full-
height moderate projection. The most popular of these
implants was the 270-g size. The median implant age at
MRI was 8 years (range, 5–11 years).
Safety
The vast majority of implants evaluated by MRI showed
no evidence of rupture 5 to 11 years after implantation
(Table 3). According to the MRI results, ﬁve implants
showed evidence of rupture, yielding a rupture prevalence
of 1.7% at a median implant age of 8 years. There were no
indeterminate results, but two scans were unreadable. The
ﬁve implants classiﬁed as ruptured showed an inverted loop
on the MRI. Three of the ﬁve implants also had subcapsular
lines.
The length of implantation at the time of rupture diag-
nosis was 6 years for one implant, 7 years for one implant,
and 8 years for three implants. No ruptures were identiﬁed
9 to 11 years after implantation.
Table 1 Demographic characteristics (n = 163 subjects)
Characteristic n %
Age at implantation (years)
18–19 0 0
20–29 10 6.1
30–39 43 26.4
40–49 58 35.6
50–59 32 19.6
60–69 18 11.0
70? 2 1.2
Race
Caucasian 160 98.2
Black/African 1 0.6
Asian 1 0.6
Hispanic 0 0
Other 1 0.6
Marital status
Single 36 22.1
Married 96 58.9
Widowed 9 5.5
Separated 7 4.3
Divorced 14 8.6
No answer 1 0.6
Education
Primary/secondary school 22 13.5
High school 89 54.6
College 52 31.9
Table 2 Surgical and device characteristics (n = 300 implants)
Characteristic n %
Implant placement
Subglandular 177 59.0
Submuscular 121 40.3
Unknown 2 0.7
Incision site
Periareolar 22 7.3
Inframammary 242 80.7
Mastectomy scar 29 9.7
Axillary 2 0.7
Breast scar 3 1.0
Other 4 1.3
Product style
Full height/full projection (FF) 5 1.7
Full height/moderate projection (FM) 132 44.0
Moderate height/moderate projection (MM) 54 18.0
Low height/full projection (LF) 1 0.3
Unknown 108 36.0
Implant age at MRI scan (years)
5 13 4.3
6 52 17.3
7 58 19.3
8 47 15.7
6 60 20.0
10 50 16.7
11 20 6.7
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baseline, 298 were not suspected of rupture, and two had
no answer. Of the 298 implants not suspected of rupture at
baseline, 5 received a diagnosis of rupture by MRI. Thus,
all the ruptures were silent and not conﬁrmed by
explantation.
Capsular contracture was detected for 5.3% of the
implants. All were grade 3, and there were no cases of
grade 4 capsular contracture. Asymmetry occurred for 7%
of the implants. The vast majority of implants (95%) had
no visible creases (wrinkling).
Of the 94 women who attempted breastfeeding before
implantation, 36.2% experienced lactation problems. After
implantation, 27 women reported attempts to breastfeed,
and 22.2% of those experienced a problem. Both before
and after implantation, the most common lactation problem
was inadequate milk production. Regarding reproduction,
25.8% reported experiencing reproductive problems before
receiving their implants, and 8.6% reported problems after
implantation. Miscarriage was the most common repro-
ductive problem both before and after implantation, and
more than one-third of the women with a postimplantation
reproductive problem (35.7%) also had a preimplanta-
tion problem. Breast carcinoma was reported for 16% of
the subjects before implantation and for 1.8% after
implantation.
Effectiveness
Several general quality-of-life measurements showed little
change after implantation (Table 4). Physical health, abil-
ity to remain active, and working capacity were marked as
unchanged by most of the subjects. One general category
that did show improvement was overall sense of well-
being, which 63% of subjects found to be better.
In contrast, most of the speciﬁc measurements showed
striking improvement after implantation. Body perception,
self-esteem, feeling of wearing clothes, personal charisma,
and attraction ability were ranked as better by the majority
of women. Clothes shopping was easier for most women,
and a large proportion stated that they felt more feminine
(Fig. 1). Notably, 91% of the subjects reported that their
breast implantation surgery overall was advantageous
(Fig. 2). The subject photographs in Fig. 3 provide evi-
dence of the natural aesthetic outcome achieved with Style
410 implantation and how well the results hold up over
time.
Table 3 Rupture summary (n = 300 implants)
Characteristic n %
MRI ﬁnding
No evidence of rupture 293 97.7
Evidence of rupture 5 1.7
Indeterminate 0 0
Unreadable 2 0.7
Prevalence of rupture (years)
50 0
6 1 2.4
7 1 1.3
8 3 6.3
90 0
10 0 0
11 0 0
Table 4 Subject quality of life
Characteristic Better
(%)
a
Unchanged
(%)
Worse
(%)
b
General changes
Physical health 16 78 6
Sense of well-being 63 33 5
Contact with other people 38 59 2
Partner/family life 43 55 3
Remain active 18 76 6
Working capacity 9 86 6
Whole Life 56 40 4
Speciﬁc Changes
Body perception 77 18 6
Self-esteem 69 28 4
Ability to exercise 15 75 10
Wearing clothes 72 21 8
Personal charisma 65 31 4
Attraction ability 61 34 4
Intimate experiences 45 46 10
Clothes shopping 64 28 9
a Includes responses of ‘‘much better,’’ ‘‘quite better,’’ and ‘‘a bit
better’’
b Includes responses of ‘‘much worse,’’ ‘‘quite worse,’’ and ‘‘a bit
worse’’
Fig. 1 Quality-of-life subject ratings on femininity
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Our study corroborated on a larger scale the results of the
Hede ´n single-center study because it was performed across
multiple European sites and also obtained longer-term data
after implantation. Whereas Hede ´n et al. [1] found a rup-
ture rate of 0.3 to 1.0% at a median implantation time of
6 years in a Swedish cohort of 144 women, our study found
a rupture rate of 1.7% at a median implantation time of
8 years. This certainly is consistent with the earlier ﬁndings
and demonstrates the long-term durability of the Style 410
implant.
An interesting ﬁnding in both studies was that no
implants were suspected of rupture at physical examina-
tion. This ﬁnding is consistent with the published literature
[3], which demonstrates that physical examination is not a
reliable way to diagnose ruptures, and that it may be
exacerbated by the more cohesive nature of the gel in the
Style 410 implant, resulting in greater difﬁculty detecting
physical signs of rupture. Notably, the MRI rupture signs
Fig. 2 Quality-of-life subject satisfaction
Fig. 3 Side and frontal views. a
View before implantation. b
View 6 months after
augmentation with a 395-g Style
410 full-height moderate
projection implant. c View
10 years after implantation
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123(e.g., inverted loop, subcapsular line) found in both studies
were the same for these highly cohesive implants as those
seen on MRIs of ruptured implants with less cohesive sil-
icone gel [4].
Although our study and the earlier Hede ´n study used the
gold standard rupture detection method of MRI, the rupture
rates were based on the rupture prevalence at a point in
time after implantation, approximately 8 years after
implantation in our study. A more accurate depiction of
rupture rates is obtained through serial MRIs of the same
subjects over time. This method was used in the U.S.
pivotal study of the Style 410 shaped gel implants, which
found a rupture incidence rate of 0.8% through 3 years
after implantation based on MRI screening at years 1 and 3
[5]. This study included 941 augmentation, reconstruction,
and revision subjects, approximately one-third of whom
participated in the serial MRI component of the study. A
third MRI at year 5 for these subjects yielded an implant
rupture incidence rate of 3.2% through 5 years [6], slightly
higher than that found in our study, but still low.
The 5.3% capsular contracture rate found in our study is
consistent with the 5.6% rate found in the study of Hede ´n
et al. [1]. Other researchers also have found little or no
capsular contracture using this textured, highly cohesive
device. Brown’s series of 150 augmentation and recon-
struction patients implanted in Canada with the Style 410
implant had no cases of Baker 3 or 4 capsular contracture
during a follow-up period up to 3 years [7]. Similarly, 263
augmentation patients in Brazil also had no Baker 3 or 4
contractures [8]. A prospective study in Spain found no
capsular contracture in 45 patients during a 1-year follow-
up period [9], and for 25 patients in Switzerland followed 4
to 5 years, no Baker 3 or 4 capsular contracture was found
[10]. The prospective U.S. pivotal study reported a 5-year
capsular contracture risk rate of 3.3% for augmentation
subjects and 9.6% for reconstruction subjects [6]. The low
rate of capsular contracture seen with the Style 410 implant
across these multiple studies is likely attributable to both
the Biocell textured implant surface and the highly cohe-
sive nature of the gel, which applies pressure to the inside
of a tight capsule [5, 7].
Our study also demonstrated the low rate of wrinkling
for the Style 410 devices, with only 5% of the implants
having any visible wrinkles. Long the bane of physicians
seeking natural results in the days of saline implants,
wrinkles are an uncommon occurrence with the highly
cohesive Style 410 implant [7]. This is also borne out in the
U.S. pivotal study, which found a wrinkling rate lower than
1% for augmentation subjects and 2.5% for reconstruction
subjects through 5 years [6]. The form-stable nature of the
Style 410 allows it to maintain its shape and upper pole ﬁll
while resisting collapse and folding, thus minimizing the
opportunity for wrinkling [7].
As in the study of Hede ´n et al. [1], quality-of-life
measurements showed postimplantation improvements in
factors such as body perception, self-esteem, and femi-
ninity as well as high rates of subject satisfaction. Whereas
other studies have shown satisfaction and psychosocial
improvement in the short term after cosmetic augmentation
[5, 11, 12]. our study presents these ﬁndings from a vantage
point of 8 years, on the average, after implantation,
pointing to the prolonged stability of the results.
Conclusion
The Style 410 anatomically shaped form-stable gel breast
implants have demonstrated long-term safety and effec-
tiveness. Up to 11 years after implantation, the vast
majority of subjects were satisﬁed with their implants, and
the complication rates, including rupture, remained low.
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